With already increased risk of weight gain in adolescents with type 1 diabetes, certain traits in these children can also be markers for even higher weight gain….
Read More »Can SGLT-2 Inhibitors Offer a Better Approach in Type 2 Diabetes?
Available studies to date looking at the benefits of using SGLT-2 inhibitors have shown positive results…. The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, offered a new therapeutic approach for the management of type 2 diabetes mellitus. The aim of this …
Read More »Increased Platelet Activation leads to CV Risk in Adolescents with Type 2 Diabetes
Adolescents with type 2 diabetes are at risk of atherosclerosis and cardiovascular disease early on in life….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #50: Pharmacotherapy of Type 2 Diabetes, Part 9
Richard S. Beaser, MD This week’s excerpt covers the following topics: What drugs block glucose absorption How to titrate this class of drugs Learn the contraindications and precautions for the glucose blocking drugs Discover which other drugs can cause serious side effects when used with drugs that block glucose absorption …
Read More »Eating White Bread Can Increase Risk for Obesity by 40%
Just 2 or more servings a day can pack on the pounds….
Read More »Path to Type 2 Diabetes May Be Paused by Eating Two Types of Nuts
Eating pistachio nuts and almonds could help protect against developing type 2 diabetes in individuals who are already at high risk….
Read More »Researchers Identify Genetic Regions Associated with Type 2 Diabetes
Analysis of DNA data reveals important information in largest diabetes genetic study to date….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #49: Pharmacotherapy of Type 2 Diabetes, Part 8
Richard S. Beaser, MD This week’s excerpt covers the following topics: Drug interactions with potential for clinical significance for metformin Contraindications and precautions for metformin Class contraindications and precautions for TZD’s Which TZD interactions are serious and how it is metabolized
Read More »Heart Risk and Death between 40% and 50% Greater for Women with Diabetes
Women with diabetes were at 40% to 50% greater risk for developing and dying from coronary heart disease than diabetic men, and sex disparities in pharmacotherapy didn’t appear to explain the excess risk….
Read More »AACE: Dapagliflozin Reduces Postprandial Glucose in Type 2 Diabetes
Dapagliflozin as an add-on therapy to glimepiride, pioglitazone, or sitagliptin significantly reduces postprandial plasma glucose in type 2 diabetes patients….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.